LILLY ELI & CO Insider Trading $DARE Dare Bioscience, Inc.
Get free email notifications about insider trading for LILLY ELI & CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LILLY ELI & CO. LILLY ELI & CO is in LILLY ELI & CO ($LLY) and 10% Owner in LILLY ELI & CO ($LLY) and Director, Chairman and CEO in LILLY ELI & CO ($LLY) and 10% Owner in UNITED THERAPEUTICS Corp ($UTHR) and Director, Chairman and CEO in UNITED THERAPEUTICS Corp ($UTHR) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in Cerulean Pharma Inc. ($CERU) and 10% Owner in Zymeworks Inc. ($ZYME) and in Coherus BioSciences, Inc. ($CHRS) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and in Avidity Biosciences, Inc. ($RNA) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Elanco Animal Health Inc ($ELAN) and 10% Owner in Sigilon Therapeutics, Inc. ($SGTX).
LILLY ELI & CO in Dare Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LILLY ELI & CO: 10% Owner
Holdings: 2,356,227 shares
Current Value: $2,733,223
Latest Transaction: Apr 15 2014
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LILLY ELI & CO in Dare Bioscience, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGLE, RNA, CHRS, CLCD, DARE, ELAN, LLY, ICGN, LPTX, SGTX, UTHR, ZYME
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Option Exercise | C | 0.00 | 4,340,831 | 0 | 0 | |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Option Exercise | C | 0.00 | 13,513,513 | 0 | 0 | |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Buy | P | 7.00 | 733,445 | 5,134,115 | 2,356,227 | 1.6 M to 2.4 M (+45.20 %) |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Buy | C | 0.00 | 199,875 | 0 | 1,622,782 | 1.4 M to 1.6 M (+14.05 %) |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Buy | C | 0.00 | 192,209 | 0 | 1,422,907 | 1.2 M to 1.4 M (+15.62 %) |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Buy | C | 0.00 | 299,213 | 0 | 1,230,698 | 931.5 K to 1.2 M (+32.12 %) |
| Apr 15 2014 | CERU | Cerulean Pharma In ... | LILLY ELI & CO | 10% Owner | Buy | C | 0.00 | 931,485 | 0 | 931,485 | 0 to 931.5 K |
Page: 1